Ramsay Bowden
@ramsaybowden
Followers
65
Following
297
Media
1
Statuses
25
Joined July 2018
@ramsaybowden has just begun her new pilot study at @Cambridge_Uni which aims to answer key questions in the diagnosis and treatment of cancer in people with A-T. Click on the link below to find out more.
actionforat.org
Improving diagnosis and treatment of cancer in Ataxia-Telangiectasia patients through whole genome sequencing in Ongoing Research
1
2
0
UK toddler has hearing restored in world first gene therapy trial. Wow 𤩠#GenomicMedicine
apple.news
Opal Sandy can hear almost perfectly after groundbreaking surgery that took just 16 minutes
1
14
64
Stripes in support of #RareDiseaseDay! Thank you to all my amazing colleagues @East_Genomics for helping to raise awareness!
1
0
4
Stellar work from @GiuseppinaDAle9, the @Jacksonlab team past and present, and colleagues @UICPharm and @imbmainz, uncovering a novel "resolvase" that deals with genotoxic protein cross-links. https://t.co/Z0gWCVqHxb
science.org
RAD54L2 resolves TOP2-DNA adducts and protects cells from anti-cancer drugs such as etoposide.
1
17
66
Professor Nik-Zainal's team @SerenaNikZainal @GeneChChKoh published a new paper today, 'The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells' to read more click here:
nature.com
Nature Genetics - The chemotherapeutic agent CX-5461 is shown to be a potent mutagen in hTERT-RPE1, HAP1 and human induced pluripotent stem cells. The compound generates distinct mutational...
0
1
1
This #ProstateCancerAwareness month weāre highlighting the role genetic testing is playing in earlier identification of prostate cancer in men. If youāre a clinician a good place to start is 𧬠@genomicsedu - https://t.co/aokLwhInYJ 𧬠@ProstateUK - https://t.co/QXA18PhSRE
0
6
9
A new opportunity has arisen in the Department of Medical Genetics (Principal Investigator: James Whitworth) to further develop a research project aimed at identifying the constitutional genetic basis of multiple primary tumours (MPT). Find out more here: https://t.co/kKJ2IbGy5A
1
4
4
Interested in rare genetic neurological disorders? Enjoy collaboration? NeuralNet Prog @TheCIMR is looking for a post-doc to work across several labs & pilot projects Reporting to @ReidLab_HSP, youāll learn a wide range of skills in cell biology & biochem https://t.co/QTJCEnrZ82
0
6
10
Dear all-new preprint of interest to the PARP field and neurodegenerative disease. First patient with PARP1 hereditary mutations https://t.co/NuF5IGgRcS
1
23
76
Come study with me and so many fantastic colleagues from @Cambridge_Uni @EBItraining @sangerinstitute @East_Genomics and @CUH_NHS. PG Cert, PG Dip, and individual modules available too. Funding via @genomicsedu for NHS staff!
š£Calling all clinicians. Are you interested in studying for a Master's in Genomic Medicine?š Applications for the University of Cambridge master's programme must be received by 31st May 2023. For more information š https://t.co/D2fCdXWEoc
#genomics #genomicseducation
1
4
15
We are hiring clinical scientists, come join the rare disease team ā¦@CUH_NHSā© ā¦@East_Genomicsā©
careers.cuh.nhs.uk
0
5
5
Excited to work for 1 year as a locum Consultant in Clinical Genetics within an academic centre, great colleagues and many opportunities? @East_Genomics @clingensoc @eshgsociety Please apply
careers.cuh.nhs.uk
0
3
6
HIRING, please RETWEET: https://t.co/QsDL6ymFFA
#EarlyDetection #ctDNA #DNArepair #organoids #CRISPR #EDxConf22 #EarlyIntervention @EarlyCancerCam @CRUKCamUrol
1
96
95
Congratulations to our @ramsaybowden! Here celebrating post viva with the lab , having successfully defending her PhD.
4
3
26
Great opportunity to work with a fantastic team!
Please retweet to help find an enthusiastic postdoc to join us on this exciting translational prostate cancer project #DDR #organoids #CRISPR
@CRUKCamEarlyDx @CRUKCamUrol
@ThePCRC @Massie_Lab Research Associate (Fixed Term) @Cambridge_Uni
https://t.co/dmzUP8BSZu
0
0
4
Read our @eLife Digest "The genomeās guardian affects gene editing"
elifesciences.org
The āguardian of the genomeā p53 may protect cells against damage but it also limits the efficiency of CRISPR-Cas9 genome editing.
0
5
15
Excited to see my paper published! Great working with @damj94, @SPJacksonGroup Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance
elifesciences.org
The protein p53 negatively impacts the ability of a CRISPR screen to discriminate between essential and non-essential genes, hence, p53 status should be considered in these screens.
1
0
14